The Center for Medicare and Medicaid Services is set to reveal the first ten prescription drugs that will be subject to price negotiations. Companies such as Merck (MRK), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY) have filed lawsuits against the Biden administration to stop the negotiations from happening